Mojello, Leonora V.
HRN: 17-17-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2024
CEFTRIAXONE 1G (VIAL)
10/01/2024
10/07/2024
IVT
2g
OD
T/c PTB Relapse; COPD Not In Acute Exacerbation
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes